Literature DB >> 10195432

The Oct-1 POU domain directs developmentally regulated nuclear translocation in Xenopus embryos.

G J Veenstra1, M T Mathu, O H Destrée.   

Abstract

Early embryonic development in Xenopus is characterized by transcriptional repression which is relieved at the mid-blastula stage. Here we show that most of the maternally inherited POU domain transcription factor Oct-1 is retained in the cytoplasm during early development, and that it gradually translocates to the nucleus around the mid-blastula transition. Overexpressed epitope-tagged Oct-1 exhibits highly similar localization properties compared to endogenous protein. The amino acid sequence that directs this developmentally regulated nuclear translocation resides in the POU domain. Our findings may suggest that cytoplasmic retention of Oct-1 facilitates or contributes to the repression of Oct-1 target genes before the mid-blastula transition.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10195432     DOI: 10.1515/BC.1999.033

Source DB:  PubMed          Journal:  Biol Chem        ISSN: 1431-6730            Impact factor:   3.915


  4 in total

1.  Use of altered-specificity binding Oct-4 suggests an absence of pluripotent cell-specific cofactor usage.

Authors:  Alexander E F Smith; Kevin G Ford
Journal:  Nucleic Acids Res       Date:  2005-10-20       Impact factor: 16.971

2.  The POU protein Oct-6 is a nucleocytoplasmic shuttling protein.

Authors:  Constanze Baranek; Elisabeth Sock; Michael Wegner
Journal:  Nucleic Acids Res       Date:  2005-10-31       Impact factor: 16.971

3.  DNA methyltransferase is actively retained in the cytoplasm during early development.

Authors:  M C Cardoso; H Leonhardt
Journal:  J Cell Biol       Date:  1999-10-04       Impact factor: 10.539

4.  Global absolute quantification reveals tight regulation of protein expression in single Xenopus eggs.

Authors:  Arne H Smits; Rik G H Lindeboom; Matteo Perino; Simon J van Heeringen; Gert Jan C Veenstra; Michiel Vermeulen
Journal:  Nucleic Acids Res       Date:  2014-07-23       Impact factor: 16.971

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.